LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway
Pancreatic ductal adenocarcinoma (PDAC) is one of most lethal cancers and is projected to be the second leading cause of cancer deaths in the United States by 2030. The lack of effective treatment and increased incidence in PDAC encourage a deeper knowledge of PDAC progression. By analyzing a long n...
Saved in:
Main Authors: | Ming Xu (Author), Ran Cui (Author), Lunhe Ye (Author), Yongkun Wang (Author), Xujing Wang (Author), Qiqi Zhang (Author), Kaijing Wang (Author), Chunxiu Dong (Author), Wenjun Le (Author), Bo Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycolysis-Related LINC02432/Hsa-miR-98-5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma
by: Peng Tan, et al.
Published: (2022) -
Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis
by: Qixuan Xu, et al.
Published: (2024) -
LINC00174 Promotes Colon Cancer Progression by Regulating Inflammation and Glycolysis by Targeting the MicroRNA-2467-3p/Enolase 3 Axis
by: Sheng Xu, et al.
Published: (2023) -
Possible Future Avenues for Rheumatoid Arthritis Therapeutics: Hippo Pathway
by: Wang T, et al.
Published: (2023) -
Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer
by: Zhaowei Sun, et al.
Published: (2021)